Annual Total Assets:
$1.39B+$245.49M(+21.54%)Summary
- As of today, ARWR annual total assets is $1.39 billion, with the most recent change of +$245.49 million (+21.54%) on September 30, 2025.
- During the last 3 years, ARWR annual total assets has risen by +$693.36 million (+100.20%).
- ARWR annual total assets is now at all-time high.
Performance
ARWR Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Total Assets:
$1.39B+$4.68M(+0.34%)Summary
- As of today, ARWR quarterly total assets is $1.39 billion, with the most recent change of +$4.68 million (+0.34%) on September 30, 2025.
- Over the past year, ARWR quarterly total assets has increased by +$245.49 million (+21.54%).
- ARWR quarterly total assets is now -11.96% below its all-time high of $1.57 billion, reached on March 31, 2025.
Performance
ARWR Quarterly Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Total Assets Formula
Total Assets = Current Assets + Non-Current Assets
ARWR Total Assets Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1Y1 Year | +21.5% | +21.5% |
| 3Y3 Years | +100.2% | +100.2% |
| 5Y5 Years | +165.1% | +165.1% |
ARWR Total Assets Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +100.2% | -12.0% | +121.2% |
| 5Y | 5-Year | at high | +165.1% | -12.0% | +177.5% |
| All-Time | All-Time | at high | >+9999.0% | -12.0% | >+9999.0% |
ARWR Total Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2025 | $1.39B(+21.5%) | $1.39B(+0.3%) |
| Jun 2025 | - | $1.38B(-12.3%) |
| Mar 2025 | - | $1.57B(+55.2%) |
| Dec 2024 | - | $1.01B(-11.1%) |
| Sep 2024 | $1.14B(+48.9%) | $1.14B(+29.0%) |
| Jun 2024 | - | $883.76M(-7.5%) |
| Mar 2024 | - | $955.15M(+52.5%) |
| Dec 2023 | - | $626.29M(-18.2%) |
| Sep 2023 | $765.55M(+10.6%) | $765.55M(-3.8%) |
| Jun 2023 | - | $795.86M(-10.7%) |
| Mar 2023 | - | $891.31M(-0.0%) |
| Dec 2022 | - | $891.49M(+28.8%) |
| Sep 2022 | $691.94M(-2.6%) | $691.94M(-8.0%) |
| Jun 2022 | - | $751.78M(+6.9%) |
| Mar 2022 | - | $703.58M(+10.2%) |
| Dec 2021 | - | $638.54M(-10.1%) |
| Sep 2021 | $710.15M(+35.9%) | $710.15M(-3.4%) |
| Jun 2021 | - | $734.93M(-2.9%) |
| Mar 2021 | - | $756.79M(+51.6%) |
| Dec 2020 | - | $499.25M(-4.5%) |
| Sep 2020 | $522.50M(+49.4%) | $522.50M(-6.0%) |
| Jun 2020 | - | $555.73M(-1.0%) |
| Mar 2020 | - | $561.08M(-4.5%) |
| Dec 2019 | - | $587.60M(+68.0%) |
| Sep 2019 | $349.85M(+213.5%) | $349.85M(+3.9%) |
| Jun 2019 | - | $336.83M(+0.9%) |
| Mar 2019 | - | $333.94M(-2.1%) |
| Dec 2018 | - | $340.95M(+205.5%) |
| Sep 2018 | $111.61M(+7.3%) | $111.61M(-1.1%) |
| Jun 2018 | - | $112.90M(-11.1%) |
| Mar 2018 | - | $127.00M(+44.0%) |
| Dec 2017 | - | $88.22M(-15.2%) |
| Sep 2017 | $104.02M(-18.8%) | $104.02M(-9.6%) |
| Jun 2017 | - | $115.08M(-9.3%) |
| Mar 2017 | - | $126.87M(-12.1%) |
| Dec 2016 | - | $144.26M(+12.5%) |
| Sep 2016 | $128.18M(-3.1%) | $128.18M(+49.9%) |
| Jun 2016 | - | $85.53M(-9.6%) |
| Mar 2016 | - | $94.61M(-15.1%) |
| Dec 2015 | - | $111.38M(-15.8%) |
| Sep 2015 | $132.27M(-27.7%) | $132.27M(-8.9%) |
| Jun 2015 | - | $145.19M(-10.6%) |
| Mar 2015 | - | $162.38M(+0.1%) |
| Dec 2014 | - | $162.14M(-11.3%) |
| Sep 2014 | $182.82M(+389.7%) | $182.82M(-7.0%) |
| Jun 2014 | - | $196.62M(-3.0%) |
| Mar 2014 | - | $202.64M(+118.6%) |
| Dec 2013 | - | $92.69M(+148.3%) |
| Sep 2013 | $37.33M(+112.8%) | $37.33M(-10.0%) |
| Jun 2013 | - | $41.49M(+234.1%) |
| Mar 2013 | - | $12.42M(-25.8%) |
| Dec 2012 | - | $16.73M(-4.6%) |
| Sep 2012 | $17.54M | $17.54M(+0.3%) |
| Jun 2012 | - | $17.49M(-23.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2012 | - | $22.75M(-15.6%) |
| Dec 2011 | - | $26.96M(+60.6%) |
| Sep 2011 | $16.79M(+35.9%) | $16.79M(+26.3%) |
| Jun 2011 | - | $13.29M(-12.8%) |
| Mar 2011 | - | $15.24M(+0.3%) |
| Dec 2010 | - | $15.19M(+22.9%) |
| Sep 2010 | $12.35M(+60.4%) | $12.35M(-15.4%) |
| Jun 2010 | - | $14.60M(+88.1%) |
| Mar 2010 | - | $7.76M(-15.0%) |
| Dec 2009 | - | $9.13M(+18.5%) |
| Sep 2009 | $7.70M(-55.4%) | $7.70M(-6.1%) |
| Jun 2009 | - | $8.20M(-19.4%) |
| Mar 2009 | - | $10.17M(-33.9%) |
| Dec 2008 | - | $15.39M(-10.8%) |
| Sep 2008 | $17.26M(-42.2%) | $17.26M(-9.8%) |
| Jun 2008 | - | $19.13M(-22.9%) |
| Mar 2008 | - | $24.82M(-19.1%) |
| Dec 2007 | - | $30.66M(+2.7%) |
| Sep 2007 | $29.85M(-13.5%) | $29.85M(-18.7%) |
| Jun 2007 | - | $36.72M(+36.5%) |
| Mar 2007 | - | $26.90M(-21.8%) |
| Dec 2006 | - | $34.39M(-0.4%) |
| Sep 2006 | $34.53M(+18.9%) | $34.53M(-14.9%) |
| Jun 2006 | - | $40.58M(-10.0%) |
| Mar 2006 | - | $45.09M(+74.2%) |
| Dec 2005 | - | $25.88M(-10.9%) |
| Sep 2005 | $29.04M(+143.7%) | $29.04M(-5.4%) |
| Jun 2005 | - | $30.71M(+110.9%) |
| Mar 2005 | - | $14.56M(+45.3%) |
| Dec 2004 | - | $10.02M(-15.9%) |
| Sep 2004 | $11.92M(+686.1%) | $11.92M(-1.9%) |
| Jun 2004 | - | $12.15M(+5.6%) |
| Mar 2004 | - | $11.51M(+440.9%) |
| Dec 2003 | - | $2.13M(+40.4%) |
| Sep 2003 | $1.52M(+2283.5%) | $1.52M(+3188.3%) |
| Jun 2003 | - | $46.10K(+6.5%) |
| Mar 2003 | - | $43.30K(-9.4%) |
| Dec 2002 | - | $47.80K(-24.8%) |
| Sep 2002 | $63.60K(+37.4%) | $63.60K(-39.5%) |
| Jun 2002 | - | $105.10K(+109.8%) |
| Mar 2002 | - | $50.10K(+3.1%) |
| Dec 2001 | - | $48.60K(+5.0%) |
| Sep 2001 | $46.30K(-28.9%) | $46.30K(-20.2%) |
| Jun 2001 | - | $58.00K(-0.5%) |
| Mar 2001 | - | $58.30K(-5.5%) |
| Dec 2000 | - | $61.70K(-5.2%) |
| Sep 2000 | $65.10K(-20.9%) | $65.10K(-2.4%) |
| Jun 2000 | - | $66.70K(-3.9%) |
| Mar 2000 | - | $69.40K(-1.7%) |
| Dec 1999 | - | $70.60K(-14.2%) |
| Sep 1999 | $82.30K(-2.9%) | $82.30K(+6.7%) |
| Jun 1999 | - | $77.10K(-3.4%) |
| Mar 1999 | - | $79.80K |
| Sep 1998 | $84.80K(-21.3%) | - |
| Sep 1997 | $107.70K | - |
FAQ
- What is Arrowhead Pharmaceuticals, Inc. annual total assets?
- What is the all-time high annual total assets for Arrowhead Pharmaceuticals, Inc.?
- What is Arrowhead Pharmaceuticals, Inc. annual total assets year-on-year change?
- What is Arrowhead Pharmaceuticals, Inc. quarterly total assets?
- What is the all-time high quarterly total assets for Arrowhead Pharmaceuticals, Inc.?
- What is Arrowhead Pharmaceuticals, Inc. quarterly total assets year-on-year change?
What is Arrowhead Pharmaceuticals, Inc. annual total assets?
The current annual total assets of ARWR is $1.39B
What is the all-time high annual total assets for Arrowhead Pharmaceuticals, Inc.?
Arrowhead Pharmaceuticals, Inc. all-time high annual total assets is $1.39B
What is Arrowhead Pharmaceuticals, Inc. annual total assets year-on-year change?
Over the past year, ARWR annual total assets has changed by +$245.49M (+21.54%)
What is Arrowhead Pharmaceuticals, Inc. quarterly total assets?
The current quarterly total assets of ARWR is $1.39B
What is the all-time high quarterly total assets for Arrowhead Pharmaceuticals, Inc.?
Arrowhead Pharmaceuticals, Inc. all-time high quarterly total assets is $1.57B
What is Arrowhead Pharmaceuticals, Inc. quarterly total assets year-on-year change?
Over the past year, ARWR quarterly total assets has changed by +$245.49M (+21.54%)